General Catalyst

General Catalyst is a venture capital firm established in 2000, headquartered in Cambridge, Massachusetts, with additional offices in North America and Europe. The company specializes in early-stage and growth equity investments, focusing on technology-driven businesses. It invests across various sectors, including consumer internet, enterprise software, fintech, health assurance, and crypto. General Catalyst provides not only capital but also mentorship and resources to accelerate the growth of its portfolio companies. To date, it has managed eight venture capital funds, totaling approximately $3.75 billion in capital commitments.

Adrian Abeijon

Investor

Mark Allen

CFO

Neeraj Arora

Managing Director, Investment Team

Juliet Bailin

Partner

Marc Bhargava

Managing Director

Chris Bischoff

Managing Director

Larry Bohn

Managing Director

Teresa Carlson

President, General Catalyst Institute

Kenneth Chenault

Managing Director and Chairman

Quentin Clark

Managing Director

Mark Crane

Partner, Investment Team

Christopher Davis

Partner, Investments

Kyle Doherty

Managing Director, Investments

Molly Blaauw Gillis

Partner and Chief of Staff

Mina Hsiang

Associate

Nmachi Jidenma

Partner

Christopher Kauffman

Principal and Member of the Investment Team

Genevieve Kinney

Principal

Zak Kukoff

Principal

Paul Kwan

Managing Director

Roy Mabrey

Partner, Investment Team

Holly Maloney McConnell

Managing Director

Karanveer Mohan

Managing Director, Investment Team

Deep Nishar

Managing Director

Dipchand Nishar

Managing Director

Reva Nohria

Principal

Trevor Oelschig

Managing Director

Tyler Olkowski

Investor

Pranay Orugunta

Healthcare Investor

Mo Punjwani

Associate, Investments

Candace Richardson

Principal

Brian Ru

Principal

Pranav Singhvi

Managing Director

Bill Skarinka

Associate

Hemant Taneja

CEO and Managing Director

Alex Tran

Managing Director, Investments

Catherine Tu

Partner, Investment Team

Elena Viboch

Partner

Andrea Wang

Principal, Early Stage Investment

Nathaniel Levy-Westhead

Partner, Investment Team

Past deals in Health Diagnostics

Sohar Health

Seed Round in 2025
Sohar Health is a technology company that specializes in behavioral health solutions. It provides an API-based platform designed to streamline eligibility verification and utilize AI-powered medical coding to automate manual workflows. This automation helps to increase patient intake and generate more revenue for healthcare providers. The platform offers tools for secure file management, utilization analytics, and reporting, enabling digital health providers to scale their operations efficiently.

Fay

Series B in 2025
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Neko Health

Series B in 2025
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.

Hippocratic AI

Series B in 2025
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Orange Health Labs

Venture Round in 2024
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.

OASYS NOW

Seed Round in 2024
OASYS NOW is a technology company focused on improving treatment access for chronic patients by efficiently connecting them with relevant clinical trials tailored to their unique health data. Utilizing advanced algorithms, the platform enhances the likelihood of patients finding personalized treatment options on a global scale. OASYS NOW emphasizes patient privacy through a privacy-by-design approach, ensuring that sensitive health data is handled securely and ethically. In addition to its patient-centric services, the company also offers solutions in legal, cybersecurity, and data-sharing, aimed at supporting organizations involved in health and genomics. By leveraging large medical datasets, OASYS NOW strives to enhance health outcomes while maintaining a strong commitment to data security and ethical practices.

Ladder

Debt Financing in 2024
Ladder is a strength training app that provides a workout plan, every single day. Fitness-seekers can access a complete strength training program on their phone, learn from an expert coach, and engage with a community that shares a passion for fitness. The company is based in Austin, Texas.

Maven Clinic

Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Doccla

Series B in 2024
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.

Better Health

Series A in 2024
Better Health is a support and supplies platform that focuses on enhancing the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The company provides expert guidance to help patients select and use the appropriate medical supplies for their needs. By delivering peer support and educational resources, Better Health aims to improve patient engagement and adherence, ultimately leading to better health outcomes and reduced healthcare costs. Trusted by various healthcare payers and providers, the company operates in 48 states and has achieved a 98% customer satisfaction rating. Co-founded by Naama Stauber Breckler and Adam Breckler, Better Health is committed to modernizing the medical supplies industry and enhancing the overall patient experience.

Fay

Series A in 2024
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Hona AI

Seed Round in 2024
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.

Transcarent

Series D in 2024
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

Karius

Series C in 2024
Karius, Inc. is a life sciences company based in Redwood City, California, with an additional office in Menlo Park. Founded in 2014, Karius specializes in generating genomic insights for infectious diseases through its innovative Karius Test. This non-invasive blood test utilizes sequencing of microbial cell-free DNA to identify and quantify a wide range of pathogens, including bacteria, DNA viruses, fungi, and parasites. The Karius Test is particularly useful in the diagnosis of complicated pneumonia, infections in immunocompromised patients, and endocarditis, enabling clinicians to make rapid and informed treatment decisions. Karius operates a CLIA-certified and CAP-accredited laboratory, providing high-complexity clinical laboratory testing and offering services for pathogen biomarker detection aimed at biopharmaceutical companies. The company is dedicated to advancing the understanding and management of infectious diseases, striving for a future where these conditions pose less of a threat to human health.

Hippocratic AI

Series A in 2024
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Eleanor Health

Venture Round in 2024
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Founded in 2019 and headquartered in Waltham, Massachusetts, Eleanor offers comprehensive, whole-person care for mental health and substance misuse. The company operates a network of outpatient clinics and also provides virtual care as well as support in patients' homes and communities. Its services include medication-assisted treatment, evidence-based outpatient care, behavioral health services, and personalized recovery plans, all aimed at facilitating a faster recovery process for individuals suffering from substance abuse disorder.

Neko Health

Series A in 2023
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.

Zageno

Venture Round in 2023
Zageno Inc. is an online retailer specializing in life science research products for scientists worldwide. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company operates a comprehensive e-commerce platform that offers over 10 million products, including preparation items for protein purification and DNA extraction, gene editing tools, PCR reagents, sequencing kits, and various laboratory accessories. Zageno aims to streamline the procurement process for researchers by providing a user-friendly interface and a unique Scientific Score rating system that features unbiased, peer-reviewed evaluations of products. This approach enhances the purchasing experience, making it more efficient and reliable for life science professionals while also serving as an effective sales channel for suppliers. Additionally, Zageno has a presence in Berlin, Germany, further extending its reach in the scientific community.

Hippocratic AI

Seed Round in 2023
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Memora Health

Venture Round in 2023
Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.

CTRL Therapeutics

Seed Round in 2023
CTRL Therapeutics is a biotechnology company based in Toronto, Canada, focused on the development of innovative cell therapies. The company has developed a microfluidic platform aimed at optimizing the detection of rare circulating tumor cells, which can be critical in cancer diagnostics. This platform is designed to facilitate the creation of liquid biopsy tests that predict patient responses to targeted therapies. By enabling the evaluation of protein expression on tumor cells, CTRL Therapeutics seeks to enhance the precision of cancer treatment and improve patient outcomes.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Breathe Well-being

Series B in 2023
Breathe Well-being is a health tech startup based in India that focuses on managing and preventing type 2 diabetes through a clinically proven program. The company provides users with personalized support, including one-on-one coaching aimed at tracking weight, meals, and activity, as well as training in cognitive behavioral therapy techniques to reduce stress. Breathe Well-being's platform promotes holistic care for individuals with chronic conditions, enabling them to adopt long-term healthy habits. By fostering community engagement through social interactions and healthy competitions, the company has successfully assisted over 10,000 members in losing weight, lowering blood sugar levels, and mitigating potential health complications.

Fay

Seed Round in 2023
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Maven Clinic

Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Doccla

Series A in 2022
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.

Redesign Health

Series C in 2022
Redesign Health is a company founded in 2018 that focuses on driving innovation in the healthcare sector. It develops technologies, tools, and insights designed to lower barriers to change within the industry. Redesign Health collaborates with exceptional founders to create and support over two dozen companies that have collectively impacted more than ten million lives across various healthcare domains, including cancer care, teleradiology, COVID-19 testing, and metabolic health. By fostering the growth of diverse healthcare solutions, Redesign Health aims to enhance the overall efficiency and effectiveness of healthcare delivery.

Homeward

Series B in 2022
Homeward is a healthcare services provider focused on improving access to quality care for the 60 million Americans living in rural communities. The company employs a multidisciplinary care team that operates both in-home and through mobile care units, utilizing technology for remote monitoring. This approach aims to connect patients with high-quality, affordable care, particularly for Medicare-eligible beneficiaries. Homeward partners with Medicare Advantage plans and assumes full financial risk for the care of its members, with the objective of enhancing health outcomes while reducing costs.

August Health

Series A in 2022
August Health is a technology company focused on enhancing the quality of care for older adults living in senior living communities. The company has developed a healthcare platform that collects data to generate insights into the wellness of seniors, facilitating access to both clinical and social support services. By leveraging this technology, August Health aims to empower aging individuals to manage their health more effectively and reduce their annual long-term care expenses. Through its innovative approach, the company addresses the specific needs of vulnerable older adults, contributing to improved healthcare outcomes in this demographic.

Examedi

Series A in 2022
Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent healthcare providers, including nurses and lab technicians. The company's telemedicine platform allows patients to book diagnostic tests and examinations from the comfort of their homes, focusing on services such as blood tests, pregnancy tests, general check-ups, and COVID-19 testing. By streamlining the scheduling process and offering affordable access to various medical tests, Examedi aims to enhance patient convenience and improve healthcare delivery.

Flexpa

Seed Round in 2022
Flexpa is a healthcare technology company founded in 2021 and based in San Francisco, California. The company specializes in developing APIs that facilitate the integration of claims histories and diagnostic test data into digital health applications and fintech platforms. By digitizing and interpreting data collected from various hardware providers, Flexpa creates analytics dashboards that help healthcare providers monitor individual and population health outcomes. This enables more informed decision-making regarding treatment plans and pharmaceutical options for patients, ultimately aiming to enhance healthcare delivery and improve patient outcomes.

Orange Health Labs

Series B in 2022
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.

Osmind

Series B in 2022
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Eleanor Health

Series C in 2022
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Founded in 2019 and headquartered in Waltham, Massachusetts, Eleanor offers comprehensive, whole-person care for mental health and substance misuse. The company operates a network of outpatient clinics and also provides virtual care as well as support in patients' homes and communities. Its services include medication-assisted treatment, evidence-based outpatient care, behavioral health services, and personalized recovery plans, all aimed at facilitating a faster recovery process for individuals suffering from substance abuse disorder.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Homeward

Series A in 2022
Homeward is a healthcare services provider focused on improving access to quality care for the 60 million Americans living in rural communities. The company employs a multidisciplinary care team that operates both in-home and through mobile care units, utilizing technology for remote monitoring. This approach aims to connect patients with high-quality, affordable care, particularly for Medicare-eligible beneficiaries. Homeward partners with Medicare Advantage plans and assumes full financial risk for the care of its members, with the objective of enhancing health outcomes while reducing costs.

Story Health

Series A in 2022
Story Health Corporation is a healthcare technology company founded in 2020 and based in Saratoga, California. The company develops intelligent embedded virtualized clinical care software tools designed to assist healthcare specialists, including neurologists and primary care physicians, in understanding medical situations and making informed clinical decisions. Story Health's platform utilizes data from high-frequency sources to enhance therapy management through virtual protocols and adaptive machine learning. By focusing on patient-centered design, Story Health aims to bridge the gap between clinical evidence and real-world patient experiences, enabling clinicians to effectively address the physiological effects of disease and therapy.

Ro

Venture Round in 2022
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Casana

Series B in 2022
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.

Transcarent

Series C in 2022
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

The Breakaway

Seed Round in 2022
The Breakaway is a developer of a motivational coaching app specifically designed for fitness enthusiasts, with a primary focus on cyclists. The application offers users intelligent goal-setting and personalized insights to facilitate faster progress in their fitness journeys. Additionally, it provides motivational feedback and tips from professional athletes, ensuring that users remain engaged and informed as they work towards achieving their goals.

Well

Series B in 2021
Well is a health technology company based in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota. Founded in 2019, Well specializes in developing an artificial intelligence-based consumer-health engagement platform and mobile application. The platform uses clinical and consumer data to provide personalized health guidance and support, helping members achieve their health goals through tailored, achievable steps. It connects users with trusted health partners and offers easy-to-understand explanations and active assistance both live and on-demand.

Cadence Solutions

Series B in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

Shyft

Seed Round in 2021
Shyft is a personalized wellness platform that offers guided nutrition, meditation, and yoga classes. Shyft offers a variety of Yoga based interactive classes and DIY content focused on managing specific conditions across women's health, chronic ailments, everyday wellness, and mental health.

Zageno

Series C in 2021
Zageno Inc. is an online retailer specializing in life science research products for scientists worldwide. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company operates a comprehensive e-commerce platform that offers over 10 million products, including preparation items for protein purification and DNA extraction, gene editing tools, PCR reagents, sequencing kits, and various laboratory accessories. Zageno aims to streamline the procurement process for researchers by providing a user-friendly interface and a unique Scientific Score rating system that features unbiased, peer-reviewed evaluations of products. This approach enhances the purchasing experience, making it more efficient and reliable for life science professionals while also serving as an effective sales channel for suppliers. Additionally, Zageno has a presence in Berlin, Germany, further extending its reach in the scientific community.

Better Health

Series A in 2021
Better Health is a support and supplies platform that focuses on enhancing the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The company provides expert guidance to help patients select and use the appropriate medical supplies for their needs. By delivering peer support and educational resources, Better Health aims to improve patient engagement and adherence, ultimately leading to better health outcomes and reduced healthcare costs. Trusted by various healthcare payers and providers, the company operates in 48 states and has achieved a 98% customer satisfaction rating. Co-founded by Naama Stauber Breckler and Adam Breckler, Better Health is committed to modernizing the medical supplies industry and enhancing the overall patient experience.

Sprinter Health

Series A in 2021
Sprinter Health is a mobile healthcare company that provides on-demand services by sending full-time nurses and phlebotomists to patients' homes. The company aims to improve access to preventive care through modern house calls, enhancing the patient experience and satisfaction. By utilizing a cost-effective hybrid care model, Sprinter Health connects patients with essential healthcare services, allowing them to receive quality care in the comfort of their own homes. This approach not only improves health outcomes but also addresses the growing demand for convenient and accessible healthcare solutions.

Orange Health Labs

Series A in 2021
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.

Breathe Well-being

Series A in 2021
Breathe Well-being is a health tech startup based in India that focuses on managing and preventing type 2 diabetes through a clinically proven program. The company provides users with personalized support, including one-on-one coaching aimed at tracking weight, meals, and activity, as well as training in cognitive behavioral therapy techniques to reduce stress. Breathe Well-being's platform promotes holistic care for individuals with chronic conditions, enabling them to adopt long-term healthy habits. By fostering community engagement through social interactions and healthy competitions, the company has successfully assisted over 10,000 members in losing weight, lowering blood sugar levels, and mitigating potential health complications.

Athelas

Series B in 2021
Athelas, Inc., founded in 2002 and based in Mountain View, California, develops and manufactures portable blood analysis devices designed for at-home use. The company's technology focuses on monitoring chronically ill patients by providing diagnostic reports from a drop of blood, helping to identify conditions such as leukemia, infections, and inflammatory diseases early. Athelas has deployed an FDA-cleared blood diagnostic device along with other sensors to manage various health metrics including Blood Pressure, Weight, Glucose, and Medication Adherence. The company operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

Cadence Solutions

Series A in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

SonderMind

Series C in 2021
SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.

OM1

Series D in 2021
OM1, Inc. is a digital health company based in Boston, Massachusetts, that specializes in developing a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform enables hospitals and health systems to fulfill requirements related to patient-reported and clinical outcomes, particularly within value-based care programs and bundle payments. By integrating predictive and prescriptive analytics, OM1's technology helps mitigate risks, lower costs, and enhance the understanding of healthcare outcomes across the care continuum. The company synthesizes and enriches clinical data to provide actionable insights that improve clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014, OM1 leverages a team of scientists, clinical experts, and software engineers to address the complexities of healthcare results.

Osana

Series A in 2021
Osana is a healthtech company that provides a patient-centric omnichannel platform designed to improve healthcare resource utilization. The platform offers subscription-based primary care services, incorporating features such as patient portals and data analysis. Additionally, it facilitates clinical analysis and studies, emergency ambulance services, and video consultations. By delivering these services, Osana enables healthcare providers to enhance their operations and improve the overall customer experience in healthcare delivery.

Osmind

Series A in 2021
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Transcarent

Series B in 2021
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

Terra API

Seed Round in 2021
Terra API is a developer of an online application programming interface that facilitates the transfer of health data across various platforms. The company's API allows applications to connect seamlessly with health apps, wearables, sensors, and blood laboratories. By accepting form-encoded request bodies and returning responses in JavaScript Object Notation, Terra API provides a streamlined method for application developers to enable users to share and access fitness data from multiple devices. This functionality enhances the integration of health-related technologies, promoting easier data exchange in the health and wellness sector.

Hallow

Series A in 2021
Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleeping soundly every night. It was founded in 2018 and is based in Chicago, Illinois.

Tempo

Series C in 2021
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Cityblock

Series C in 2021
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Ro

Series D in 2021
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Ossium Health

Series B in 2021
Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.

Sprinter Health

Seed Round in 2021
Sprinter Health is a mobile healthcare company that provides on-demand services by sending full-time nurses and phlebotomists to patients' homes. The company aims to improve access to preventive care through modern house calls, enhancing the patient experience and satisfaction. By utilizing a cost-effective hybrid care model, Sprinter Health connects patients with essential healthcare services, allowing them to receive quality care in the comfort of their own homes. This approach not only improves health outcomes but also addresses the growing demand for convenient and accessible healthcare solutions.

Truvian Sciences

Series C in 2021
Truvian Sciences Inc. is a diagnostic company based in San Diego, California, focused on revolutionizing the blood testing industry. Incorporated in 2015, the company has developed an automated benchtop system that delivers lab-accurate results for a variety of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all from a single sample. Additionally, Truvian's software system enables healthcare practitioners to efficiently deliver test results to patients through a user-friendly platform.

Casana

Series A in 2021
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.

Elephant Healthcare

Series A in 2021
Elephant Healthcare Limited is a technology company established in 2018 and located in London, United Kingdom. The company focuses on designing and developing a digital health system aimed at addressing critical challenges in global healthcare. Founded by medical professionals, Elephant Healthcare leverages extensive medical knowledge to create a global digital health network that connects various components of the healthcare ecosystem. Its software platform digitizes medical clinics, enabling enhanced connectivity and offering tools that can transform primary care. By utilizing blockchain and decentralized infrastructure, the platform links existing healthcare services and facilitates the development of new health applications, ultimately aiming to improve patient care and reduce costs, particularly in low-income regions.

Curai Health

Series B in 2020
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company specializes in providing affordable primary care through a chat-based interface that integrates artificial intelligence with human clinicians. This approach leverages advanced machine learning tools to streamline patient interactions and enhance diagnostic accuracy. By creating a responsive learning healthcare system, Curai Health aims to make high-quality primary care accessible to everyone, reducing the overall cost of care delivery. The service is available directly to consumers and can also be accessed through enterprise partnerships, emphasizing its commitment to improving healthcare accessibility and affordability.

Well

Series A in 2020
Well is a health technology company based in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota. Founded in 2019, Well specializes in developing an artificial intelligence-based consumer-health engagement platform and mobile application. The platform uses clinical and consumer data to provide personalized health guidance and support, helping members achieve their health goals through tailored, achievable steps. It connects users with trusted health partners and offers easy-to-understand explanations and active assistance both live and on-demand.

Cityblock

Series C in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Story Health

Seed Round in 2020
Story Health Corporation is a healthcare technology company founded in 2020 and based in Saratoga, California. The company develops intelligent embedded virtualized clinical care software tools designed to assist healthcare specialists, including neurologists and primary care physicians, in understanding medical situations and making informed clinical decisions. Story Health's platform utilizes data from high-frequency sources to enhance therapy management through virtual protocols and adaptive machine learning. By focusing on patient-centered design, Story Health aims to bridge the gap between clinical evidence and real-world patient experiences, enabling clinicians to effectively address the physiological effects of disease and therapy.

Transcarent

Series A in 2020
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

Osmind

Seed Round in 2020
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Tempo

Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Ro

Series C in 2020
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

SonderMind

Series B in 2020
SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.

Karius

Series B in 2020
Karius, Inc. is a life sciences company based in Redwood City, California, with an additional office in Menlo Park. Founded in 2014, Karius specializes in generating genomic insights for infectious diseases through its innovative Karius Test. This non-invasive blood test utilizes sequencing of microbial cell-free DNA to identify and quantify a wide range of pathogens, including bacteria, DNA viruses, fungi, and parasites. The Karius Test is particularly useful in the diagnosis of complicated pneumonia, infections in immunocompromised patients, and endocarditis, enabling clinicians to make rapid and informed treatment decisions. Karius operates a CLIA-certified and CAP-accredited laboratory, providing high-complexity clinical laboratory testing and offering services for pathogen biomarker detection aimed at biopharmaceutical companies. The company is dedicated to advancing the understanding and management of infectious diseases, striving for a future where these conditions pose less of a threat to human health.

Elysium

Series C in 2019
Elysium Health, Inc., established in 2014 and headquartered in New York, specializes in the development and sale of health supplements. The company focuses on two primary areas: cellular health and optimization, and long-term brain health. It offers a proprietary formulation of natural compounds, designed to support overall well-being at the cellular level, which is sold directly to consumers via its online platform. Additionally, Elysium provides a biological age testing solution.

OM1

Series C in 2019
OM1, Inc. is a digital health company based in Boston, Massachusetts, that specializes in developing a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform enables hospitals and health systems to fulfill requirements related to patient-reported and clinical outcomes, particularly within value-based care programs and bundle payments. By integrating predictive and prescriptive analytics, OM1's technology helps mitigate risks, lower costs, and enhance the understanding of healthcare outcomes across the care continuum. The company synthesizes and enriches clinical data to provide actionable insights that improve clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014, OM1 leverages a team of scientists, clinical experts, and software engineers to address the complexities of healthcare results.

Well

Seed Round in 2019
Well is a health technology company based in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota. Founded in 2019, Well specializes in developing an artificial intelligence-based consumer-health engagement platform and mobile application. The platform uses clinical and consumer data to provide personalized health guidance and support, helping members achieve their health goals through tailored, achievable steps. It connects users with trusted health partners and offers easy-to-understand explanations and active assistance both live and on-demand.

Zageno

Series B in 2019
Zageno Inc. is an online retailer specializing in life science research products for scientists worldwide. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company operates a comprehensive e-commerce platform that offers over 10 million products, including preparation items for protein purification and DNA extraction, gene editing tools, PCR reagents, sequencing kits, and various laboratory accessories. Zageno aims to streamline the procurement process for researchers by providing a user-friendly interface and a unique Scientific Score rating system that features unbiased, peer-reviewed evaluations of products. This approach enhances the purchasing experience, making it more efficient and reliable for life science professionals while also serving as an effective sales channel for suppliers. Additionally, Zageno has a presence in Berlin, Germany, further extending its reach in the scientific community.

Curai Health

Series A in 2018
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company specializes in providing affordable primary care through a chat-based interface that integrates artificial intelligence with human clinicians. This approach leverages advanced machine learning tools to streamline patient interactions and enhance diagnostic accuracy. By creating a responsive learning healthcare system, Curai Health aims to make high-quality primary care accessible to everyone, reducing the overall cost of care delivery. The service is available directly to consumers and can also be accessed through enterprise partnerships, emphasizing its commitment to improving healthcare accessibility and affordability.

OM1

Series B in 2018
OM1, Inc. is a digital health company based in Boston, Massachusetts, that specializes in developing a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform enables hospitals and health systems to fulfill requirements related to patient-reported and clinical outcomes, particularly within value-based care programs and bundle payments. By integrating predictive and prescriptive analytics, OM1's technology helps mitigate risks, lower costs, and enhance the understanding of healthcare outcomes across the care continuum. The company synthesizes and enriches clinical data to provide actionable insights that improve clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014, OM1 leverages a team of scientists, clinical experts, and software engineers to address the complexities of healthcare results.

Ro

Seed Round in 2017
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

OM1

Series A in 2017
OM1, Inc. is a digital health company based in Boston, Massachusetts, that specializes in developing a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform enables hospitals and health systems to fulfill requirements related to patient-reported and clinical outcomes, particularly within value-based care programs and bundle payments. By integrating predictive and prescriptive analytics, OM1's technology helps mitigate risks, lower costs, and enhance the understanding of healthcare outcomes across the care continuum. The company synthesizes and enriches clinical data to provide actionable insights that improve clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014, OM1 leverages a team of scientists, clinical experts, and software engineers to address the complexities of healthcare results.

PatientBank

Seed Round in 2016
PatientBank is a medical information-sharing platform that facilitates the online request and management of medical records from various healthcare providers, including doctors and hospitals. The service enables patients to gather and store their medical records securely, allowing for easy sharing with care providers, hospitals, and family members. By streamlining the process of retrieving and sharing medical information, PatientBank enhances the efficiency of health checkups and improves communication between patients and their healthcare teams. The platform aims to empower individuals in managing their health information, making it more accessible when needed.

Elysium

Series B in 2016
Elysium Health, Inc., established in 2014 and headquartered in New York, specializes in the development and sale of health supplements. The company focuses on two primary areas: cellular health and optimization, and long-term brain health. It offers a proprietary formulation of natural compounds, designed to support overall well-being at the cellular level, which is sold directly to consumers via its online platform. Additionally, Elysium provides a biological age testing solution.

TearScience

Series D in 2016
TearScience, Inc. is a medical device company based in Morrisville, North Carolina, specializing in the identification, diagnosis, and treatment of meibomian gland disease (MGD), a primary cause of dry eye affecting millions worldwide. Founded in 2005, TearScience has developed innovative devices to address evaporative dry eye, including the LipiFlow Activator, which delivers automated therapeutic energies to treat the meibomian glands, and the LipiScan, an imaging tool that allows eye care professionals to assess gland health. The company's integrated system enables effective management of MGD, which is often underestimated despite being a leading contributor to dry eye symptoms such as irritation, dryness, and visual disturbances. As a subsidiary of Johnson & Johnson Surgical Vision, TearScience continues to advance its mission of improving patient outcomes through early detection and treatment of this chronic condition.

Oceans Healthcare

Venture Round in 2013
Oceans Healthcare is a behavioral health provider established in 2004, dedicated to healing and long-term recovery for individuals, particularly older adults. The company operates 33 locations, including 23 inpatient hospital campuses across the Southeast, and specializes in addressing cognitive and mental health symptoms such as depression, anxiety, and schizophrenia, as well as behavioral changes related to medication management and substance abuse. In 2020, Oceans treated over 18,000 individuals, demonstrating a commitment to comprehensive care throughout the recovery process. The company is recognized for its consistent achievement of high performance metrics on national quality and safety measurements, as assessed by the Centers for Medicare and Medicaid Services and The Joint Commission. Additionally, Oceans Healthcare has earned a place on the Inc. 5000 list of the fastest-growing private companies in America for four consecutive years.

SynapDx

Series B in 2012
SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

OvaScience

Series B in 2012
OvaScience, Inc. is a fertility company focused on discovering and commercializing innovative treatment options for women experiencing infertility. Founded in 2011 and headquartered in Waltham, Massachusetts, OvaScience developed proprietary technology based on the identification of egg precursor (EggPC) cells, enabling new approaches to fertility treatments. Its key offerings include OvaPrime, which aims to restore a woman's natural egg production by utilizing her own EggPC cells; OvaTure, which matures these cells into fertilizable eggs outside the body without hormone stimulation; and AUGMENT, which enhances fertilization and pregnancy rates using mitochondria from the woman’s EggPC cells. The company’s technology is exclusively licensed from Harvard Medical School and Massachusetts General Hospital, and it has been supported by a team of experts in reproductive science and embryology. OvaScience was initially known as Ovastem, Inc. before rebranding in 2011. In December 2018, OvaScience was acquired by Millendo Therapeutics, marking a significant shift in its operational focus.

Lose It!

Series A in 2012
Lose It! is a weight loss application designed to help individuals achieve and maintain a healthy weight. The platform allows users to set personalized weight loss goals and provides tools to track daily food intake and exercise. With a focus on community support, members can engage in competitive challenges and connect with others for motivation and accountability. The app generates tailored plans and calorie budgets based on individual health information and goals, utilizing a comprehensive database of food and exercise options. By combining proven nutritional science with user-friendly software, Lose It! aims to empower individuals to adopt healthier lifestyles and successfully reach their weight loss objectives.

SynapDx

Series A in 2010
SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

TearScience

Series C in 2010
TearScience, Inc. is a medical device company based in Morrisville, North Carolina, specializing in the identification, diagnosis, and treatment of meibomian gland disease (MGD), a primary cause of dry eye affecting millions worldwide. Founded in 2005, TearScience has developed innovative devices to address evaporative dry eye, including the LipiFlow Activator, which delivers automated therapeutic energies to treat the meibomian glands, and the LipiScan, an imaging tool that allows eye care professionals to assess gland health. The company's integrated system enables effective management of MGD, which is often underestimated despite being a leading contributor to dry eye symptoms such as irritation, dryness, and visual disturbances. As a subsidiary of Johnson & Johnson Surgical Vision, TearScience continues to advance its mission of improving patient outcomes through early detection and treatment of this chronic condition.

Lose It!

Seed Round in 2010
Lose It! is a weight loss application designed to help individuals achieve and maintain a healthy weight. The platform allows users to set personalized weight loss goals and provides tools to track daily food intake and exercise. With a focus on community support, members can engage in competitive challenges and connect with others for motivation and accountability. The app generates tailored plans and calorie budgets based on individual health information and goals, utilizing a comprehensive database of food and exercise options. By combining proven nutritional science with user-friendly software, Lose It! aims to empower individuals to adopt healthier lifestyles and successfully reach their weight loss objectives.

GTESS Corp

Series B in 2005
GTESS specializes in providing outsourced front-end solutions for the healthcare administrative services market. The company offers a range of services including claims conversion and cleaning, correspondence management, and coordination of benefits, which encompasses Medicare. By utilizing advanced artificial intelligence and neural network technology, GTESS enhances the efficiency of claims processing and document management. The company's solutions enable managed care organizations, third-party administrators, and health maintenance organizations to streamline their operations, reduce costs, and improve service quality. Through partnerships with leading healthcare payers and networks, GTESS aids its clients in focusing on strategic initiatives while positively impacting their financial performance.

GTESS Corp

Series A in 2004
GTESS specializes in providing outsourced front-end solutions for the healthcare administrative services market. The company offers a range of services including claims conversion and cleaning, correspondence management, and coordination of benefits, which encompasses Medicare. By utilizing advanced artificial intelligence and neural network technology, GTESS enhances the efficiency of claims processing and document management. The company's solutions enable managed care organizations, third-party administrators, and health maintenance organizations to streamline their operations, reduce costs, and improve service quality. Through partnerships with leading healthcare payers and networks, GTESS aids its clients in focusing on strategic initiatives while positively impacting their financial performance.

Sprinter Health

Sprinter Health is a mobile healthcare company that provides on-demand services by sending full-time nurses and phlebotomists to patients' homes. The company aims to improve access to preventive care through modern house calls, enhancing the patient experience and satisfaction. By utilizing a cost-effective hybrid care model, Sprinter Health connects patients with essential healthcare services, allowing them to receive quality care in the comfort of their own homes. This approach not only improves health outcomes but also addresses the growing demand for convenient and accessible healthcare solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.